Botox maker AbbVie said headwinds in China hurt sales for its aesthetic pharmaceuticals division in the June quarter, and lowered its outlook for those products in both the U.S. and in China.

Allergan’s Botox has another clinical use after the FDA granted approval for children with upper limb spasticity. The drug was first approved clinically for upper limb spasticity in adults in ...

Some of Allergan's top shareholders have approached potential activist investors to gauge their interest in pushing for change at the Botox-maker, according to people familiar with the matter.

“At Allergan Aesthetics, we’ve been in the aesthetics market from the very beginning with the launch of Botox Cosmetic,” says Carrie Strom, Global President of Allergan Aesthetics and S ...

The FDA has approved Allergan’s Botox to treat lower-limb spasticity in children, further extending the use of the drug – widely used as a wrinkle treatment – in therapeutic indications.

The acquisition will give AbbVie access to Allergan's portfolio of profitable beauty drugs, including Botox. Watch Allergan trade live. Botox-maker Allergan jumped as much as 30% before the ...

(RTTNews) - Allergan Aesthetics, an AbbVie company (ABBV), announced that FDA approves BOTOX® Cosmetic for temporary improvement in the appearance of moderate to severe vertical bands connecting ...

Anyone interested in learning more about BOTOX® Cosmetic treatment is encouraged to visit botoxcosmetic.com and enroll in Alle, the Allergan Aesthetics loyalty rewards program. In serving ...